Nakypova, S.; Smolobochkin, A.; Rizbayeva, T.; Turmanov, R.; Gazizov, A.; Akylbekov, N.; Zhapparbergenov, R.; Narmanova, R.; Ibadullayeva, S.; Zalaltdinova, A.;
et al. Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations. Pharmaceuticals 2025, 18, 1056.
https://doi.org/10.3390/ph18071056
AMA Style
Nakypova S, Smolobochkin A, Rizbayeva T, Turmanov R, Gazizov A, Akylbekov N, Zhapparbergenov R, Narmanova R, Ibadullayeva S, Zalaltdinova A,
et al. Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations. Pharmaceuticals. 2025; 18(7):1056.
https://doi.org/10.3390/ph18071056
Chicago/Turabian Style
Nakypova, Saltanat, Andrey Smolobochkin, Tanzilya Rizbayeva, Rakhymzhan Turmanov, Almir Gazizov, Nurgali Akylbekov, Rakhmetulla Zhapparbergenov, Roza Narmanova, Saltanat Ibadullayeva, Alena Zalaltdinova,
and et al. 2025. "Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations" Pharmaceuticals 18, no. 7: 1056.
https://doi.org/10.3390/ph18071056
APA Style
Nakypova, S., Smolobochkin, A., Rizbayeva, T., Turmanov, R., Gazizov, A., Akylbekov, N., Zhapparbergenov, R., Narmanova, R., Ibadullayeva, S., Zalaltdinova, A., Syzdykbayev, M., Voronina, J., Lyubina, A., Voloshina, A., Klimanova, E., Sashenkova, T., Mishchenko, D., & Burilov, A.
(2025). Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations. Pharmaceuticals, 18(7), 1056.
https://doi.org/10.3390/ph18071056
